These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

138 related items for PubMed ID: 16679364

  • 1. Evidence that nystatin channels form at the boundaries, not the interiors of lipid domains.
    Helrich CS, Schmucker JA, Woodbury DJ.
    Biophys J; 2006 Aug 01; 91(3):1116-27. PubMed ID: 16679364
    [Abstract] [Full Text] [Related]

  • 2. Role of the sterol superlattice in the partitioning of the antifungal drug nystatin into lipid membranes.
    Wang MM, Sugar IP, Chong PL.
    Biochemistry; 1998 Aug 25; 37(34):11797-805. PubMed ID: 9718302
    [Abstract] [Full Text] [Related]

  • 3. Controlled delivery of membrane proteins to artificial lipid bilayers by nystatin-ergosterol modulated vesicle fusion.
    de Planque MR, de Planque MR, Mendes GP, Zagnoni M, Sandison ME, Fisher KH, Berry RM, Watts A, Morgan H.
    IEE Proc Nanobiotechnol; 2006 Apr 25; 153(2):21-30. PubMed ID: 16671820
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Nystatin-induced liposome fusion. A versatile approach to ion channel reconstitution into planar bilayers.
    Woodbury DJ, Miller C.
    Biophys J; 1990 Oct 25; 58(4):833-9. PubMed ID: 1701101
    [Abstract] [Full Text] [Related]

  • 8. Effect of sterol side chain on ion channel formation by amphotericin B in lipid bilayers.
    Nakagawa Y, Umegawa Y, Takano T, Tsuchikawa H, Matsumori N, Murata M.
    Biochemistry; 2014 May 20; 53(19):3088-94. PubMed ID: 24762132
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Comparative molecular dynamics study of lipid membranes containing cholesterol and ergosterol.
    Czub J, Baginski M.
    Biophys J; 2006 Apr 01; 90(7):2368-82. PubMed ID: 16399829
    [Abstract] [Full Text] [Related]

  • 11. Effect of membrane structure on the action of polyenes II: nystatin activity along the phase diagram of ergosterol- and cholesterol-containing POPC membranes.
    González-Damián J, Ortega-Blake I.
    J Membr Biol; 2010 Sep 01; 237(1):41-9. PubMed ID: 20871987
    [Abstract] [Full Text] [Related]

  • 12. Cholesterol and ergosterol influence nystatin surface aggregation: relation to pore formation.
    Coutinho A, Silva L, Fedorov A, Prieto M.
    Biophys J; 2004 Nov 01; 87(5):3264-76. PubMed ID: 15315952
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Cholesterol superlattice modulates the activity of cholesterol oxidase in lipid membranes.
    Wang MM, Olsher M, Sugár IP, Chong PL.
    Biochemistry; 2004 Mar 02; 43(8):2159-66. PubMed ID: 14979712
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Ion channel behavior of amphotericin B in sterol-free and cholesterol- or ergosterol-containing supported phosphatidylcholine bilayer model membranes investigated by electrochemistry and spectroscopy.
    Huang W, Zhang Z, Han X, Tang J, Wang J, Dong S, Wang E.
    Biophys J; 2002 Dec 02; 83(6):3245-55. PubMed ID: 12496093
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. How do sterols determine the antifungal activity of amphotericin B? Free energy of binding between the drug and its membrane targets.
    Neumann A, Baginski M, Czub J.
    J Am Chem Soc; 2010 Dec 29; 132(51):18266-72. PubMed ID: 21126070
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.